{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:06:32Z","timestamp":1785186392292,"version":"3.55.0"},"reference-count":54,"publisher":"Bentham Science Publishers Ltd.","issue":"36","funder":[{"DOI":"10.13039\/501100004787","name":"The Oman Research Council","doi-asserted-by":"publisher","award":["BFP\/RGP\/HSS\/19\/198"],"award-info":[{"award-number":["BFP\/RGP\/HSS\/19\/198"]}],"id":[{"id":"10.13039\/501100004787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Carbonic anhydrase II (CA-II) is associated with calcification, tumorigenicity, epilepsy,\nosteoporosis, and several other physiological or pathological processes. CA-II inhibitors can be used to\nreduce the intraocular pressure usually associated with glaucoma.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In search for potent CA-II inhibitors, a series of thiosemicarbazone derivatives (3a-u) was synthesized.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This series was evaluated against bovine and human carbonic anhydrase II (bCA-II and hCA-II) and\ntheir docking studies were carried out.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In the preliminary screening, most of the compounds exhibited significant inhibition of bCA-II and\nhCA-II. The predictive structure-activity relationship suggested that the thiosemicarbazide moiety plays a key\nrole in the inhibition of enzyme activity and substitution at R position and has a remarkable contribution to the\noverall activity. The kinetic studies of the most active inhibitors of bCA-II (3d, 3e, 3l, 3f, and 3p) and hCA-II\n(3g) were performed against bCA-II and hCA-II, respectively to investigate their mode of inhibition and dissociation\nconstants (Ki).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Subsequently, (3e, 3f, 3l and 3p) were identified as competitive inhibitors of bCA-II with Ki values\nof 5.02-14.70 \u03bcM, while (3d) as a noncompetitive inhibitor of bCA-II (Ki = 2.5 \u00b1 0.015 \u03bcM), however, (3g)\ndemonstrated competitive inhibition of hCA-II with a Ki value of 5.95 \u00b1 0.002 \u03bcM. The selectivity index\nreflects that compound (3g) is more selective for hCA-II. The binding modes of these compounds with bCA-II\nand hCA-II were investigated by structure-based molecular docking, and the docking results are in complete\nagreement with the experimental findings.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612828666220729105849","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T04:48:50Z","timestamp":1659329330000},"page":"3010-3022","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inhibitory Efficacy of Thiosemicarbazones for Carbonic Anhydrase II (Bovine and\nHuman) as a Target of Calcification and Tumorigenicity"],"prefix":"10.2174","volume":"28","author":[{"given":"Majid","family":"Khan","sequence":"first","affiliation":[{"name":"Natural and Medical Sciences Research Center, University of Nizwa, PO Box 33, 616 Birkat Al Mauz, Nizwa, Oman"},{"name":"International\nCenter for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry, University of Karachi, Karachi-75270,\nPakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobia Ahsan","family":"Halim","sequence":"additional","affiliation":[{"name":"Natural and Medical Sciences Research Center, University of Nizwa, PO Box 33, 616 Birkat Al Mauz, Nizwa, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[{"name":"Institute of Chemical Sciences, Bahauddin Zakariya University, Multan 60800, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Islam","sequence":"additional","affiliation":[{"name":"Institute of Chemical Sciences, Bahauddin Zakariya University, Multan 60800, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Tariq","family":"Shehzad","sequence":"additional","affiliation":[{"name":"Institute of Chemical Sciences, Bahauddin Zakariya University, Multan 60800, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Ibrar","sequence":"additional","affiliation":[{"name":"Department of Chemistry,\nFaculty of Natural Sciences, The University of Haripur, Haripur, KPK-22620, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, COMSATS\nUniversity Islamabad Abbottabad Campus, Abbottabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najat","family":"Marraiki","sequence":"additional","affiliation":[{"name":"Department of Botany and Microbiology, College of Science,\nKing Saud University, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Uddin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid\nUniversity, Abha 62529, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmal","family":"Khan","sequence":"additional","affiliation":[{"name":"Natural and Medical Sciences Research Center, University of Nizwa, PO Box 33, 616 Birkat Al Mauz, Nizwa, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[{"name":"Natural and Medical Sciences Research Center, University of Nizwa, PO Box 33, 616 Birkat Al Mauz, Nizwa, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1574-6976.2000.tb00546.x","volume":"24","author":"Smith K.S.","year":"2000","unstructured":"Smith K.S.; Ferry J.G.; Prokaryotic carbonic anhydrases. FEMS Microbiol Rev 2000,24(4),335-366","journal-title":"FEMS Microbiol Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ardp.201600183","volume":"349","author":"Aksu K.","year":"2016","unstructured":"Aksu K.; \u00d6zgeri\u015f B.; Taslimi P.; Naderi A.; G\u00fcl\u00e7in \u0130.; G\u00f6ksu S.; Antioxidant activity, acetylcholinesterase, and carbonic anhydrase inhibitory properties of novel ureas derived from phenethylamines. Arch Pharm (Weinheim) 2016,349(12),944-954","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3109\/14756366.2016.1160077","volume":"31","author":"Gul H.I.","year":"2016","unstructured":"Gul H.I.; Tugrak M.; Sakagami H.; Taslimi P.; Gulcin I.; Supuran C.T.; Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3 H -indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides. J Enzyme Inhib Med Chem 2016,31(6),1619-1624","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/newbio235131a0","volume":"235","author":"Liljas A.","year":"1972","unstructured":"Liljas A.; Kannan K.K.; Bergst\u00e9n P.C.; Crystal structure of human carbonic anhydrase C. Nat New Biol 1972,235(57),131-137","journal-title":"Nat New Biol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3109\/14756366.2015.1057723","volume":"31","author":"Topal F.","year":"2016","unstructured":"Topal F.; Nar M.; Gocer H.; Antioxidant activity of taxifolin: An activity-structure relationship. J Enzyme Inhib Med Chem 2016,31(4),674-683","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3109\/14756366.2015.1132710","volume":"31","author":"Camadan Y.","year":"2016","unstructured":"Camadan Y.; \u00d6zdemir H.; Gulcin \u0130.; Purification and characterization of dihydropyrimidine dehydrogenase enzyme from sheep liver and determination of the effects of some anaesthetic and antidepressant drugs on the enzyme activity. J Enzyme Inhib Med Chem 2016,31(6),1335-1341","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1994.tb19909.x","volume":"219","author":"Liljas A.","year":"1994","unstructured":"Liljas A.; H\u00e5kansson K.; Jonsson B.H.; Xue Y.; Inhibition and catalysis of carbonic anhydrase. Recent crystallographic analyses. Eur J Biochem 1994,219(1-2),1-10","journal-title":"Eur J Biochem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1073\/pnas.090091397","volume":"97","author":"Lane T.W.","year":"2000","unstructured":"Lane T.W.; Morel F.M.M.; A biological function for cadmium in marine diatoms. Proc Natl Acad Sci USA 2000,97(9),4627-4631","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1042\/BJ20051102","volume":"392","author":"Hilvo M.","year":"2005","unstructured":"Hilvo M.; Tolvanen M.; Clark A.; Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem J 2005,392(1),83-92","journal-title":"Biochem J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1016\/j.bmc.2013.03.077","volume":"21","author":"Aksu K.","year":"2013","unstructured":"Aksu K.; Nar M.; Tan\u00e7 M.; The synthesis of sulfamide analogues of dopamine related compounds and their carbonic anhydrase inhibitory properties. Bioorg Med Chem 2013,21,2925-2931","journal-title":"Bioorg Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3109\/14756366.2016.1149479","volume":"31","author":"Ozgun D.O.","year":"2016","unstructured":"Ozgun D.O.; Yamali C.; Gul H.I.; Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase. J Enzyme Inhib Med Chem 2016,31(6),1498-1501","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/14756366.2016.1170014","volume":"31","author":"Turan B","year":"2016","unstructured":"Turan B; \u015eendil K; \u015eeng\u00fcl E; The synthesis of some \u03b2-lactams and investigation of their metal-chelating activity, carbonic anhydrase and acetylcholinesterase inhibition profiles. J Enzyme Inhib Med Chem 2016,31(sup1),79-88","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.etap.2016.04.011","volume":"44","author":"Kucuk M.","year":"2016","unstructured":"Kucuk M.; Gulcin \u0130.; Purification and characterization of the carbonic anhydrase enzyme from Black Sea trout (Salmo trutta Labrax Coruhensis) kidney and inhibition effects of some metal ions on enzyme activity. Environ Toxicol Pharmacol 2016,44,134-139","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bioorg.2015.04.006","volume":"60","author":"\u00d6zta\u015fk\u0131n N.","year":"2015","unstructured":"\u00d6zta\u015fk\u0131n N.; \u00c7etinkaya Y.; Taslimi P.; G\u00f6ksu S.; G\u00fcl\u00e7in \u0130.; Antioxidant and acetylcholinesterase inhibition properties of novel bromophenol derivatives. Bioorg Chem 2015,60,49-57","journal-title":"Bioorg Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/ardp.201300228","volume":"346","author":"G\u00f6\u00e7er H.","year":"2013","unstructured":"G\u00f6\u00e7er H.; Ak\u0131nc\u0131o\u011flu A.; \u00d6zta\u015fk\u0131n N.; G\u00f6ksu S.; G\u00fcl\u00e7in \u0130.; Synthesis, antioxidant, and antiacetylcholinesterase activities of sulfonamide derivatives of dopamine-related compounds. Arch Pharm (Weinheim) 2013,346(11),783-792","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3906\/kim-1403-5","volume":"38","author":"Topal M.","year":"2014","unstructured":"Topal M.; G\u00fcl\u00e7in \u0130.; Rosmarinic acid: A potent carbonic anhydrase isoenzymes inhibitor. Turk J Chem 2014,38,894-902","journal-title":"Turk J Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1016\/j.bmc.2014.04.007","volume":"22","author":"G\u00fcney M.","year":"2014","unstructured":"G\u00fcney M.; Co\u015fkun A.; Topal F.; Da\u015ftan A.; G\u00fcl\u00e7in \u0130.; Supuran C.T.; Oxidation of cyanobenzocycloheptatrienes: Synthesis, photooxygenation reaction and carbonic anhydrase isoenzymes inhibition properties of some new benzotropone derivatives. Bioorg Med Chem 2014,22(13),3537-3543","journal-title":"Bioorg Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1002\/chem.200600159","volume":"12","author":"Temperini C.","year":"2006","unstructured":"Temperini C.; Scozzafava A.; Vullo D.; Supuran C.T.; Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: Engineering proton-transfer processes within the active site of an enzyme. Chemistry 2006,12(27),7057-7066","journal-title":"Chemistry"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/14756366.2016.1238367","volume":"32","author":"Taslimi P.","year":"2017","unstructured":"Taslimi P.; Sujayev A.; Mamedova S.; Synthesis and bioactivity of several new hetaryl sulfonamides. J Enzyme Inhib Med Chem 2017,32(1),137-145","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0006-2952(99)00419-0","volume":"59","author":"Finch R.A.","year":"2000","unstructured":"Finch R.A.; Liu M.C.; Grill S.P.; Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity. Biochem Pharmacol 2000,59(8),983-991","journal-title":"Biochem Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0065-2571(98)00017-X","volume":"39","author":"Finch R.A.","year":"1999","unstructured":"Finch R.A.; Liu M.C.; Cory A.H.; Cory J.G.; Sartorelli A.C.; Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): An inhibitor of ribonucleotide reductase with antineoplastic activity. Adv Enzyme Regul 1999,39(1),3-12","journal-title":"Adv Enzyme Regul"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/bmj.2.5409.621","volume":"2","author":"Kune G.A.","year":"1964","unstructured":"Kune G.A.; To-day\u2019s Drugs: Methisazone. BMJ 1964,2(5409),621-1","journal-title":"BMJ"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a121340","volume":"94","author":"Heiner G.G.","year":"1971","unstructured":"Heiner G.G.; Fatima N.; Russell P.K.; Field trials of methisazone as a prophylactic agent against smallpox. Am J Epidemiol 1971,94(5),435-449","journal-title":"Am J Epidemiol"},{"key":"ref=24","first-page":"4661","volume":"2","author":"Singhal S.","year":"2013","unstructured":"Singhal S.; Arora S.; Agarwal S.; Sharma R.; Singhal N.; A review on potential biological activities of thiosemicarbazides. World J Pharm Pharm Sci 2013,2,4661-4681","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1021\/jm070445z","volume":"50","author":"Kalinowski D.S.","year":"2007","unstructured":"Kalinowski D.S.; Yu Y.; Sharpe P.C.; Design, synthesis, and characterization of novel iron chelators: Structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents. J Med Chem 2007,50(15),3716-3729","journal-title":"J Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.bmc.2004.12.050","volume":"13","author":"Abid M.","year":"2005","unstructured":"Abid M.; Azam A.; Synthesis and antiamoebic activities of 1-N-substituted cyclised pyrazoline analogues of thiosemicarbazones. Bioorg Med Chem 2005,13(6),2213-2220","journal-title":"Bioorg Med Chem"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4049\/jimmunol.67.4.305","volume":"67","author":"Hamre D.","year":"1951","unstructured":"Hamre D.; Brownlee K.A.; Donovick R.; Studies on the chemotherapy of vaccinia virus. II. The activity of some thiosemicarbazones. J Immunol 1951,67(4),305-312","journal-title":"J Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bioorg.2015.06.004","volume":"61","author":"Hameed A.","year":"2015","unstructured":"Hameed A.; Khan K.M.; Zehra S.T.; Synthesis, biological evaluation and molecular docking of N-phenyl thiosemicarbazones as urease inhibitors. Bioorg Chem 2015,61,51-57","journal-title":"Bioorg Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"63886","DOI":"10.1039\/C6RA12827K","volume":"6","author":"Hameed A.","year":"2016","unstructured":"Hameed A.; Yaqub M.; Hussain M.; Coumarin-based thiosemicarbazones as potent urease inhibitors: Synthesis, solid state self-assembly and molecular docking. RSC Advances 2016,6(68),63886-63894","journal-title":"RSC Advances"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"9351","DOI":"10.1039\/C5NJ01879J","volume":"39","author":"Hameed A.","year":"2015","unstructured":"Hameed A.; Shafiq Z.; Yaqub M.; Me 3 N-promoted synthesis of 2,3,4,4a-tetrahydroxanthen-1-one: Preparation of thiosemicarbazone derivatives, their solid state self-assembly and antimicrobial properties. New J Chem 2015,39(12),9351-9357","journal-title":"New J Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bioorg.2018.12.006","volume":"87","author":"Shehzad M.T.","year":"2019","unstructured":"Shehzad M.T.; Imran A.; Njateng G.S.S.; Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study. Bioorg Chem 2019,87,857-866","journal-title":"Bioorg Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/0929867053507315","volume":"12","author":"Borges F.","year":"2005","unstructured":"Borges F.; Roleira F.; Milhazes N.; Santana L.; Uriarte E.; Simple coumarins and analogues in medicinal chemistry: Occurrence, synthesis and biological activity. Curr Med Chem 2005,12(8),887-916","journal-title":"Curr Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1517\/13543776.2012.678835","volume":"22","author":"Kontogiorgis C.","year":"2012","unstructured":"Kontogiorgis C.; Detsi A.; Hadjipavlou-Litina D.; Coumarin-based drugs: A patent review (2008 \u2013 present). Expert Opin Ther Pat 2012,22(4),437-454","journal-title":"Expert Opin Ther Pat"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00044-012-0026-x","volume":"22","author":"Patel R.V.","year":"2013","unstructured":"Patel R.V.; Kumari P.; Rajani D.P.; Chikhalia K.H.; Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl\/benzothiazolyl acetamides as antimicrobial and antituberculosis agents. Med Chem Res 2013,22(1),195-210","journal-title":"Med Chem Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1021\/jm00400a003","volume":"31","author":"Turner S.","year":"1988","unstructured":"Turner S.; Myers M.; Gadie B.; Antihypertensive thiadiazoles. 1. Synthesis of some 2-aryl-5-hydrazino-1,3,4-thiadiazoles with vasodilator activity. J Med Chem 1988,31(5),902-906","journal-title":"J Med Chem"},{"key":"ref=36","first-page":"1074","volume":"45","author":"Hanna M.A.","year":"1995","unstructured":"Hanna M.A.; Girges M.M.; Rasala D.; Gawinecki R.; Synthesis and pharmacological evaluation of some novel 5-(pyrazol-3-yl)thiadiazole and oxadiazole derivatives as potential hypoglycemic agents. Arzneimittelforschung 1995,45(10),1074-1078","journal-title":"Arzneimittelforschung"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ejmech.2015.07.010","volume":"101","author":"Thakur A.","year":"2015","unstructured":"Thakur A.; Singla R.; Jaitak V.; Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies. Eur J Med Chem 2015,101,476-495","journal-title":"Eur J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ejmech.2015.08.033","volume":"102","author":"Emami S.","year":"2015","unstructured":"Emami S.; Dadashpour S.; Current developments of coumarin-based anti-cancer agents in medicinal chemistry. Eur J Med Chem 2015,102,611-630","journal-title":"Eur J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1016\/j.bmc.2014.05.032","volume":"22","author":"Sandhu S.","year":"2014","unstructured":"Sandhu S.; Bansal Y.; Silakari O.; Bansal G.; Coumarin hybrids as novel therapeutic agents. Bioorg Med Chem 2014,22(15),3806-3814","journal-title":"Bioorg Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1076\/phbi.40.3.221.5832","volume":"40","author":"Zhang H.","year":"2002","unstructured":"Zhang H.; Qiu S.; Tamez P.; Antimalarial agents from plants II. Decursivine, a new antimalarial indole alkaloid from Rhaphidophora decursiva. Pharm Biol 2002,40(3),221-224","journal-title":"Pharm Biol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40659-018-0209-0","volume":"52","author":"Farooq U.","year":"2019","unstructured":"Farooq U.; Naz S.; Shams A.; Isolation of dihydrobenzofuran derivatives from ethnomedicinal species Polygonum barbatum as anti-cancer compounds. Biol Res 2019,52(1),1","journal-title":"Biol Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s12272-014-0468-4","volume":"38","author":"Ferreira-J\u00fanior J.C.","year":"2015","unstructured":"Ferreira-J\u00fanior J.C.; Conserva L.M.; Lyra Lemos R.P.; de Omena-Neta G.C.; Cavalcante-Neto A.; Barreto E.; Isolation of a dihydrobenzofuran lignan, icariside E4, with an antinociceptive effect from Tabebuia roseo-alba (Ridley) Sandwith (Bignoniaceae) bark. Arch Pharm Res 2015,38(6),950-956","journal-title":"Arch Pharm Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3389\/fphar.2017.00825","volume":"8","author":"Corr\u00eaa M.F.","year":"2017","unstructured":"Corr\u00eaa M.F.; Barbosa \u00c1.J.R.; Teixeira L.B.; Pharmacological characterization of 5-substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel antagonists for the histamine H3 and H4 receptors with anti-inflammatory potential. Front Pharmacol 2017,8,825","journal-title":"Front Pharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.201800134","volume":"15","author":"Dias H.J.","year":"2018","unstructured":"Dias H.J.; Patroc\u00ednio A.B.; Pagotti M.C.; Schistosomicidal activity of dihydrobenzofuran neolignans. Chem Biodivers 2018,15(7)","journal-title":"Chem Biodivers"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/slct.201703024","volume":"3","author":"Fukui M.J.","year":"2018","unstructured":"Fukui M.J.; Dias H.J.; Severiano M.E.; Antimicrobial and cytotoxic activity of dihydrobenzofuran neolignans. ChemistrySelect 2018,3(6),1836-1839","journal-title":"ChemistrySelect"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1515\/hc-2017-0245","volume":"24","author":"Wan L.","year":"2018","unstructured":"Wan L.; Zihui Y.; Aixi H.; Synthesis and fungicidal activities of 2-{[(2-(1H-1, 2, 4-triazol-1-yl)-ethylidene) amino] oxy} alkana-mides containing dihydrobenzofuran. Heterocycl Commun 2018,24,339-344","journal-title":"Heterocycl Commun"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s42250-019-00043-4","volume":"2","author":"Amole K.L.","year":"2019","unstructured":"Amole K.L.; Bello I.A.; Oyewale A.O.; Synthesis, characterization and antibacterial activities of new fluorinated chalcones. Chemistry Africa 2019,2(1),47-55","journal-title":"Chemistry Africa"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bioorg.2019.03.008","volume":"87","author":"Islam M.","year":"2019","unstructured":"Islam M.; Khan A.; Shehzad M.T.; Synthesis and characterization of new thiosemicarbazones, as potent urease inhibitors: In vitro and in silico studies. Bioorg Chem 2019,87,155-162","journal-title":"Bioorg Chem"},{"key":"ref=49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103404","volume":"94","author":"Shehzad M.T.","year":"2020","unstructured":"Shehzad M.T.; Khan A.; Islam M.; Synthesis, characterization and molecular docking of some novel hydrazonothiazolines as urease inhibitors. Bioorg Chem 2020,94","journal-title":"Bioorg Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/bi00853a037","volume":"6","author":"Pocker Y.","year":"1967","unstructured":"Pocker Y.; Meany J.E.; The catalytic versatility of erythrocyte carbonic anhydrase. II. Kinetic studies of the enzyme-catalyzed hydration of pyridine aldehydes. Biochemistry 1967,6(1),239-246","journal-title":"Biochemistry"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1107\/S0907444904003166","volume":"60","author":"Saito R.","year":"2004","unstructured":"Saito R.; Sato T.; Ikai A.; Tanaka N.; Structure of bovine carbonic anhydrase II at 1.95 \u00c5 resolution. Acta Crystallogr D Biol Crystallogr 2004,60(4),792-795","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1002\/pro.5560071201","volume":"7","author":"Boriack-Sjodin P.A.","year":"1998","unstructured":"Boriack-Sjodin P.A.; Zeitlin S.; Christianson D.W.; Structural analysis of inhibitor binding to human carbonic anhydrase II. Protein Sci 1998,7(12),2483-2489","journal-title":"Protein Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","volume":"77","author":"Nepali K.","year":"2014","unstructured":"Nepali K.; Sharma S.; Sharma M.; Bedi P.M.S.; Dhar K.L.; Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur J Med Chem 2014,77,422-487","journal-title":"Eur J Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00044-021-02723-8","volume":"30","author":"Avula S.K.","year":"2021","unstructured":"Avula S.K.; Rehman N.U.; Khan M.; New synthetic 1H-1,2,3-triazole derivatives of 3-O-acetyl-\u03b2-boswellic acid and 3-O-acetyl-11-keto-\u03b2-boswellic acid from Boswellia sacra inhibit carbonic anhydrase II in vitro. Med Chem Res 2021,30(6),1185-1198","journal-title":"Med Chem Res"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220729105849","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207112\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220729105849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T09:27:50Z","timestamp":1691746070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207112\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":54,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612828666220729105849","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}